| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d21b2a7132df4c0d5387c8b2ff1ef4f |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 |
| filingDate |
1996-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00e5677e760d595d35ebce6599019f4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d54e8ee7775a80549c4468eea7d55848
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40ad2aa26d07bcd5a6cdb887efe291c4 |
| publicationDate |
1997-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H09315969-A |
| titleOfInvention |
Ibudilast-containing sustained-release pharmaceutical composition and method for producing the same |
| abstract |
(57) 【Abstract】 PROBLEM TO BE SOLVED: 3) A conventional sustained release preparation of ibudilast It has stable dissolution characteristics even when stored in a high temperature environment, which eliminates the disadvantage that the drug release from the drug product cannot be controlled in an environment of 0 ° C or higher and side effects due to a sharp increase in blood concentration during administration are eliminated. Provided is a sustained release formulation of ibudilast. SOLUTION: Ibudilast is contained by mixing sustained-release particles containing a mixture of ibudilast and a sustained-release polymer, and enteric-coated sustained-release particles obtained by further coating the sustained-release particles with an enteric polymer. Sustained-release pharmaceutical composition. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012144577-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8202456-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10463648-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007509970-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011251959-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10292966-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100780479-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11179369-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009510036-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007510656-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008059792-A1 |
| priorityDate |
1996-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |